BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1900303)

  • 1. Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells.
    Hilton DJ; Nicola NA; Metcalf D
    J Cell Physiol; 1991 Feb; 146(2):207-15. PubMed ID: 1900303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of leukemia inhibitory factor to murine myoblasts in culture.
    Bower J; Vakakis N; Nicola NA; Austin L
    J Cell Physiol; 1995 Jul; 164(1):93-8. PubMed ID: 7790402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP; Bruce AG
    New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unsolved enigmas of leukemia inhibitory factor.
    Metcalf D
    Stem Cells; 2003; 21(1):5-14. PubMed ID: 12529546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice.
    Hilton DJ; Nicola NA; Waring PM; Metcalf D
    J Cell Physiol; 1991 Sep; 148(3):430-9. PubMed ID: 1918172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the early differentiation pathway of monoparental embryonic stem cells is not affected by the expression of LIF receptors.
    Garcia Tobalina R; Uranga JA; Aréchaga J
    Int J Dev Biol; 1996; Suppl 1():213S-214S. PubMed ID: 9087766
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemia inhibitory factor and neurotrophins support overlapping populations of rat nodose sensory neurons in culture.
    Thaler CD; Suhr L; Ip N; Katz DM
    Dev Biol; 1994 Feb; 161(2):338-44. PubMed ID: 8313987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of leukemia inhibitory factor during mammalian development.
    Shellard J; Perreau J; Brûlet P
    Eur Cytokine Netw; 1996 Dec; 7(4):699-712. PubMed ID: 9010672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner.
    Kucia M; Wojakowski W; Reca R; Machalinski B; Gozdzik J; Majka M; Baran J; Ratajczak J; Ratajczak MZ
    Arch Immunol Ther Exp (Warsz); 2006; 54(2):121-35. PubMed ID: 16648972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
    Begley CG; Rasko JE; Curtis D; Takagi K; Metcalf D; Hilton D; Roberts B; Nicola NA; Rossner MT
    Exp Hematol; 1996 Aug; 24(10):1247-57. PubMed ID: 8765501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
    Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
    Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are LIF and related cytokines functionally equivalent?
    Piquet-Pellorce C; Grey L; Mereau A; Heath JK
    Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pleiotropic actions of leukemia inhibitory factor.
    Gough NM; Williams RL
    Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
    Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor induces a hypertrophic response mediated by gp130 in murine cardiac myocytes.
    Matsui H; Fujio Y; Kunisada K; Hirota H; Yamauchi-Takihara K
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):149-62. PubMed ID: 8884986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.